MDxHealth SA
▲ 0 upgrades / ▼ 1 downgrades / 0 reiterations from 1 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | BTIG | downgrade | Buy → Neutral | — | 52% |
| Aug 21, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Aug 14, 2026 | Lake Street | maintain | Buy → Buy | — | 47% |
| May 14, 2026 | Lake Street | maintain | Buy → Buy | — | 47% |
| May 14, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| May 14, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Dec 23, 2025 | BTIG | reiterate | Buy → Buy | $7 | 52% |
| Nov 13, 2025 | TD Cowen | maintain | Buy → Buy | $7 | 54% |
| Nov 13, 2025 | Lake Street | maintain | Buy → Buy | $9 | 47% |
| Nov 13, 2025 | BTIG | maintain | Buy → Buy | $7 | 52% |
| Nov 7, 2024 | Piper Sandler | maintain | Overweight → Overweight | $6 | 54% |
| Oct 31, 2024 | Lake Street | initiate | — → Buy | $7 | 47% |
| Mar 7, 2024 | Piper Sandler | maintain | Overweight → Overweight | $7 | 54% |
| Mar 7, 2024 | BTIG | maintain | Buy → Buy | $8 | 52% |
No cross-platform signals in the last 90 days